Phyllis Hamberlin of Vicksburg knows others set the foundation for the therapy she receives today for myeloma, a cancer of the plasma cells. Now, she's doing the same: participating in a clinical trial that her doctor at UMMC hopes will improve this therapy for her and for others. “It's been working for us,” she said recently. For this trial she had an additional incentive: It helps pay for some of her medications. “In a good clinical trial, you try to find a good standard of care and add something to it,” said Dr. Tondre Buck, a hematologist/oncologist at UMMC and Hamberlin's primary physician. “You wouldn't have gotten to the standard of care without clinical trials.” Clinical trials are crucial in getting the latest research into clinics where they can make a difference in human lives, said Dr. Tate Thigpen, head of the UMMC Division of Hematology/Oncology. Trials such as the one Hamberlin entered help refine treatment recommendations, he said.
|